leadf
logo-loader
viewArcadia Biosciences Inc
(
NASDAQ:RKDA
)

Arcadia Biosciences teams up with GoodMills Innovation to bring GoodWheat products to Europe

The company’s GoodWheat portfolio of improved wheats includes attributes such as higher fiber, fewer calories and reduced allergenicity, as well as an extended shelf life

Wheat
GoodMills is the leading milling company in Europe, operating 25 flour mills in total

Arcadia Biosciences Inc (NASDAQ:RKDA) has revealed it is collaborating with The GoodMills Group GmbH, the largest milling company in Europe, to commercialize its GoodWheat products.

The company’s GoodWheat portfolio of improved wheats includes attributes such as higher fiber, fewer calories and reduced allergenicity, as well as extended shelf life. The ingredients are created by Arcadia's proprietary ArcaTech platform, which accelerates discovery, development and breeding of new wheat varieties using non-genetically modified techniques, the company said.

"We are pleased to be working with GoodMills to introduce valued nutritional benefits to wheat-based products across Europe," Arcadia CEO Matthew Plavan said in a statement. "GoodMills is an excellent partner with a strong focus on innovation. Together we aim to introduce uniquely healthy products for the retail, consumer and food service sectors in Europe, beginning in 2020."

READ: Arcadia strikes partnership with Three Farm Daughters to develop and market GoodWheat branded products

The milling industry in Europe produces 35 million tons of flour annually with a turnover of €15 billion, Arcadia noted. GoodMills is the leading milling company in Europe, operating 25 flour mills in total.

"GoodMills Innovation is recognized as one of the world's leading innovators in the area of grain-based ingredients that are both highly functional and nutritional," said Michael Gusko, head of innovation at GoodMills.

"Recent market research highlights accelerated key consumer trends in 2020, including health and immunity enhancement, natural authentic cooking and sustainable plant protein. We see tremendous potential in Arcadia's portfolio of specialty wheats to help us meet these trends," he added. 

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

Quick facts: Arcadia Biosciences Inc

Follow
NASDAQ:RKDA

Price: 2.04 USD

Market Cap: $45.23 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Destiny Pharma Presenting at the One2One Virtual Forum - 16th September 2021

Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. The Company is developing novel antimicrobial drugs from its “in-house” XF platform and also from recently acquired Biotherapeutic products that...

4 days, 14 hours ago

2 min read